Company

Technology

Discover scalable, instrument-free single cell sequencing technology from Parse Bioscience

Technology Overview


Resources

Explore our collection of resources to learn more about technology and its applications from leading researchers

Resources Overview

Company

Providing researchers single cell sequencing with unprecedented scale and ease

About Parse

Discovering mediators of chemoresistance in vitro tumoroid models of pancreatic cancer


Pancreatic cancer remains one of the deadliest malignancies in large part due to therapeutic resistance. Chemotherapy and radiotherapy remodel the tumor microenvironment, and interactions between cancer-associated fibroblasts and cancer cells modulate the therapeutic response and contribute to chemoresistance.

To identify and characterize candidate interactions between cancer cells and fibroblasts that may mediate therapeutic resistance, we utilized the Parse Evercode WT V2 assay to profile cells in a tumoroid co-culture model between tumor-derived cells and pancreatic stellate cells.

Sample NameCells AssayedExposureSample Type
Co-culture UntreatedTumor-CAF Co-cultureCells
Co-culture TreatedTumor-CAF Co-culture5FUCells

 

Pre-print:
Therapy-associated remodeling of pancreatic cancer revealed by single-cell spatial transcriptomics and optimal transport analysis
https://doi.org/10.1101/2023.06.28.546848

Spatial molecular imaging is combined with single-cell sequencing to characterize the tumor microenvironment of human pancreatic cancer.

"We were able to perform high-quality and cost-effective single-cell RNA-sequencing with the Evercode kit"

-William Hwang, PI, Massachusetts General Hospital Center for Cancer Research

We're your partners in single cell

Reach out for a quote or for help planning your next experiment.